SCHEMBL756990

SCHEMBL756990

CN(C)c1cc(N2C(=O)C(C)(C)Oc3cc(NS(C)(=O)=O)ccc32)ccc1F.CS(=O)(=O)Nc1ccc2c(c1)OCC(=O)N2c1ccc(F)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 6/20 0.56
KMT2A Q03164 2/20 0.35
PIK3CD O00329 4/20 0.33
GAA P10253 2/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
BRD4 O60885 1/20 0.32
PIK3R1 P27986 3/20 0.32
MTOR P42345 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754378 0.88 NR3C2 (0.72) NR3C2BRD4AR
SCHEMBL756352 0.86 NR3C2 (0.50) NR3C2KMT2APIK3CDGAAHPGD
SCHEMBL743757 0.86 NR3C2 (0.75) NR3C2KMT2AGAAHPGDMAPK1
SCHEMBL755215 0.79 NR3C2 (0.75) NR3C2KMT2AGAAHPGDMAPK1
SCHEMBL755857 0.78 NR3C2 (0.80) NR3C2KMT2AMEN1BRD4AR
SCHEMBL754783 0.78 NR3C2 (0.72) NR3C2KMT2AGAAHPGDMAPK1
SCHEMBL756244 0.78 NR3C2 (0.53) NR3C2KMT2APIK3CDGAAHPGD
SCHEMBL755904 0.76 NR3C2 (0.77) NR3C2BRD4SMN1; SMN2AR
SCHEMBL756493 0.76 NR3C2 (0.70) NR3C2KMT2AGAAHPGDMAPK1
SCHEMBL754306 0.76 NR3C2 (0.79) NR3C2GAAHPGDMAPK1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984345-B9 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-21 EP claimed
EP-1984345-B1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2011-08-31 EP claimed